Diagnos Inc (ADK) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.539x

Based on the latest financial reports, Diagnos Inc (ADK) has a cash flow conversion efficiency ratio of 0.539x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-828.10K ≈ $-599.04K USD) by net assets (CA$-1.54 Million ≈ $-1.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Diagnos Inc - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Diagnos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ADK liabilities breakdown for a breakdown of total debt and financial obligations.

Diagnos Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Akari Therapeutics PLC
NASDAQ:AKTX
-0.093x
Otto Energy Ltd
AU:OEL
0.142x
Kadestone Capital Corp
V:KDSX
-0.401x
Fondia Oyj
HE:FONDIA
-0.113x
Intersport Polska S.A.
WAR:IPO
0.401x
Lancashire Holdings Ltd
LSE:LRE
0.018x
OXE Marine AB
ST:OXE
-0.326x
PeterLabs Holdings Bhd
KLSE:0171
0.107x

Annual Cash Flow Conversion Efficiency for Diagnos Inc (2002–2025)

The table below shows the annual cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ADK company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$233.11K
≈ $168.63K
CA$-3.64 Million
≈ $-2.63 Million
-15.604x -2076.03%
2024-03-31 CA$-3.05 Million
≈ $-2.21 Million
CA$-2.41 Million
≈ $-1.74 Million
0.790x -18.33%
2023-03-31 CA$-1.95 Million
≈ $-1.41 Million
CA$-1.88 Million
≈ $-1.36 Million
0.967x -94.61%
2022-03-31 CA$-113.51K
≈ $-82.11K
CA$-2.04 Million
≈ $-1.47 Million
17.954x +1598.12%
2021-03-31 CA$1.13 Million
≈ $818.98K
CA$-1.36 Million
≈ $-981.49K
-1.198x +17.44%
2020-03-31 CA$1.82 Million
≈ $1.32 Million
CA$-2.64 Million
≈ $-1.91 Million
-1.452x -418.05%
2019-03-31 CA$-5.08 Million
≈ $-3.68 Million
CA$-2.32 Million
≈ $-1.68 Million
0.456x -26.02%
2018-03-31 CA$-3.64 Million
≈ $-2.63 Million
CA$-2.24 Million
≈ $-1.62 Million
0.617x +92.48%
2017-03-31 CA$-5.58 Million
≈ $-4.03 Million
CA$-1.79 Million
≈ $-1.29 Million
0.321x -54.80%
2016-03-31 CA$-3.15 Million
≈ $-2.28 Million
CA$-2.23 Million
≈ $-1.62 Million
0.709x -94.44%
2015-03-31 CA$-224.85K
≈ $-162.65K
CA$-2.87 Million
≈ $-2.07 Million
12.748x +464.40%
2014-03-31 CA$346.95K
≈ $250.98K
CA$-1.21 Million
≈ $-878.01K
-3.498x -204.12%
2013-03-31 CA$1.75 Million
≈ $1.26 Million
CA$-2.01 Million
≈ $-1.45 Million
-1.150x -41.39%
2012-03-31 CA$2.34 Million
≈ $1.70 Million
CA$-1.91 Million
≈ $-1.38 Million
-0.814x +31.73%
2011-03-31 CA$1.18 Million
≈ $855.17K
CA$-1.41 Million
≈ $-1.02 Million
-1.192x -56.73%
2010-03-31 CA$1.98 Million
≈ $1.43 Million
CA$-1.51 Million
≈ $-1.09 Million
-0.760x -4.87%
2009-03-31 CA$2.41 Million
≈ $1.74 Million
CA$-1.75 Million
≈ $-1.26 Million
-0.725x -557420.15%
2008-03-31 CA$4.21 Million
≈ $3.04 Million
CA$-547.00
≈ $-395.69
0.000x +99.98%
2007-03-31 CA$1.42 Million
≈ $1.03 Million
CA$-876.30K
≈ $-633.90K
-0.616x +60.42%
2006-03-31 CA$793.68K
≈ $574.14K
CA$-1.24 Million
≈ $-894.18K
-1.557x +86.16%
2005-03-31 CA$161.61K
≈ $116.91K
CA$-1.82 Million
≈ $-1.32 Million
-11.252x -1503.98%
2004-03-31 CA$-128.75K
≈ $-93.14K
CA$-103.19K
≈ $-74.64K
0.801x -73.66%
2003-03-31 CA$-264.64K
≈ $-191.44K
CA$-805.06K
≈ $-582.37K
3.042x -56.40%
2002-03-31 CA$-325.75K
≈ $-235.64K
CA$-2.27 Million
≈ $-1.64 Million
6.978x --

About Diagnos Inc

V:ADK Canada Health Information Services
Market Cap
$16.95 Million
CA$23.43 Million CAD
Market Cap Rank
#25530 Global
#1024 in Canada
Share Price
CA$0.23
Change (1 day)
-2.13%
52-Week Range
CA$0.19 - CA$0.38
All Time High
CA$1.95
About

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more